We only have this paper's title and publication details.
Read it at the sourceDemonstrates improved pathologic complete response with pembrolizumab plus chemotherapy in early-stage breast cancer, suggesting enhanced neoadjuvant efficacy.
ClinicalTrials.gov Identifier: NCT01042379.
No takes yet. Share an insight, caveat, or question.
Nanda et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: